NCT01228435 2017-12-04IPI-504 in NSCLC Patients With ALK TranslocationsMassachusetts General HospitalPhase 2 Terminated3 enrolled 5 charts
NCT01427946 2014-11-13Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung CancerInfinity Pharmaceuticals, Inc.Phase 1/2 Completed47 enrolled
NCT01362400 2014-05-19A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung CancerInfinity Pharmaceuticals, Inc.Phase 2 Completed226 enrolled
NCT00004065 2013-06-24Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerMemorial Sloan Kettering Cancer CenterPhase 1 Completed
NCT00431015 2012-12-10Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)Infinity Pharmaceuticals, Inc.Phase 1/2 Completed88 enrolled